论文部分内容阅读
目前临床医生根据对乳腺癌雌激素受体（ＥＲ）和孕激素受体（ＰＲ）测定来指导治疗方案。Ｗｉｔｌｉｆ综合文献报道ＥＲ和ＰＲ阳性时进行内分泌治疗有效率达７８％，而ＥＲ和ＰＲ阴性时仅１０％，有明显的差异性［１］。故对乳腺癌组织中ＥＲ和ＰＲ测定，有助于治疗方案的...
Current clinicians guide treatment regimens based on the determination of estrogen receptor (ER) and progesterone receptor (PR) in breast cancer. Witlif comprehensive literature reported ER and PR positive endocrine therapy when the effective rate of 78%, while ER and PR negative when only 10%, there are significant differences [1]. Therefore, the determination of ER and PR in breast cancer tissue contributes to the treatment plan...